Action Nurexone Biologic - NRX

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,61

Prix Achat

0,61

Prix Vente

0,65

Volume échangé

73 010

0,61 Fourchette du Jour 0,65

0,32 Plage de 52 semaines 1,19

Cap du marché

29,432M

Clôture Veille

0,62

Ouverture

0,63

Dernière Transaction

500

0.61

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

45 653

Actions en circulation

48 249 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-8,09

Bénéfice par action (BPA)

-0,08

Chiffre d'affairess

Bénéfice net

-3,64M

Secteur

Miscellaneous Metal Ores,nec

Industrie

Pharmaceutical Preparations

Site Web

www.nurexone.com

Siège social

Toronto, Ontario, Can

Fondé

2011

Nurexone Biologic Inc est coté dans le secteur Miscellaneous Metal Ores de la TSX Venture Exchange avec le ticker NRX. Le dernier cours de clôture d'Nurexone Biologic était de $0,62. Au cours de la dernière année, les actions de Nurexone Biologic ont été négociées dans une fourchette de prix de $ 0,32 à $ 1,19.

Nurexone Biologic compte actuellement 48 249 000 actions en circulation. La capitalisation boursière d'Nurexone Biologic est de $29,91 million. Nurexone Biologic a un ratio cours/bénéfice (ratio PE) de -8.09.

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

TORONTO and HAIFA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (“NurExone” or the “Company”) is pleased to announce the formation...

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

TORONTO and HAIFA, Israel, Jan. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (“NurExone” or the “Company”), a developer of exosome-based...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.05	8.92857142857	0.56	0.65	0.56	41454	0.60799381	CS
4	-0.04	-6.15384615385	0.65	0.69	0.54	29332	0.60811291	CS
12	-0.05	-7.57575757576	0.66	0.83	0.54	45653	0.7036947	CS
26	0.01	1.66666666667	0.6	0.83	0.52	37869	0.66241925	CS
52	0.29	90.625	0.32	1.19	0.32	79042	0.74880854	CS
156	-0.19	-23.75	0.8	1.19	0.1	34675	0.69553043	CS
260	-0.19	-23.75	0.8	1.19	0.1	34675	0.69553043	CS

NRX - Frequently Asked Questions (FAQ)

What is the current Nurexone Biologic share price?

The current share price of Nurexone Biologic is $ 0,61

How many Nurexone Biologic shares are in issue?

Nurexone Biologic has 48 249 000 shares in issue

What is the market cap of Nurexone Biologic?

The market capitalisation of Nurexone Biologic is CAD 29,91M

What is the 1 year trading range for Nurexone Biologic share price?

Nurexone Biologic has traded in the range of $ 0,32 to $ 1,19 during the past year

What is the PE ratio of Nurexone Biologic?

The price to earnings ratio of Nurexone Biologic is -8,09

What is the reporting currency for Nurexone Biologic?

Nurexone Biologic reports financial results in USD

What is the latest annual profit for Nurexone Biologic?

The latest annual profit of Nurexone Biologic is USD -3,64M

What is the registered address of Nurexone Biologic?

The registered address for Nurexone Biologic is SUITE 1600, 1 FIRST CANADIAN PLACE, 100 KING STREET, TORONTO, ONTARIO, M5X 1G5

What is the Nurexone Biologic website address?

The website address for Nurexone Biologic is www.nurexone.com

Which industry sector does Nurexone Biologic operate in?

Nurexone Biologic operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ADG.HArcus Development Group Inc	$ 0,025 (400,00%)	260,5k
CEN.HClaren Energy Corp	$ 0,155 (342,86%)	25k
SGUSignature Resources Ltd	$ 0,06 (100,00%)	1,2M
BOCABocana Resources Corp	$ 0,01 (100,00%)	64k
CPICarlton Precious Inc	$ 0,09 (80,00%)	34,5k
RGIReco International Group Inc	$ 0,01 (-50,00%)	28k
CNST.PConstellation Capital Corp	$ 0,04 (-42,86%)	20k
GAR.HGreen Arrow Resources Inc	$ 0,025 (-37,50%)	2k
CBLUClear Blue Technologies International Inc	$ 0,02 (-33,33%)	11k
MTLOMartello Technologies Group Inc	$ 0,01 (-33,33%)	4,74k
LUCALuca Mining Corp	$ 1,02 (5,15%)	7,95M
OMIOrosur Mining Inc	$ 0,245 (44,12%)	2,57M
AGAGArgenta Silver Corp	$ 0,26 (6,12%)	2,32M
SXLSlam Exploration Ltd	$ 0,025 (25,00%)	1,88M
CHSComprehensive Healthcare Systems Inc	$ 0,01 (0,00%)	1,87M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Nurexone Biologic Inc (NRX)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Nurexone Biologic Inc

NRX Dernières nouvelles

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

NurExone Biologic Secures Master Cell Bank

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA

NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

NurExone Biologic Secures Master Cell Bank

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA

NRX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Nurexone Biologic Inc (NRX) Cours

Nurexone Biologic Inc (NRX)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Nurexone Biologic Inc

NRX Dernières nouvelles

NRX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités